Compare LCTX & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LCTX | WSBF |
|---|---|---|
| Founded | 1990 | 1921 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 391.1M | 336.0M |
| IPO Year | 1996 | 2013 |
| Metric | LCTX | WSBF |
|---|---|---|
| Price | $1.64 | $18.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 72.1K |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.24% |
| EPS Growth | N/A | ★ 46.53 |
| EPS | N/A | ★ 1.48 |
| Revenue | ★ $14,556,000.00 | N/A |
| Revenue This Year | $109.40 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.52 |
| Revenue Growth | ★ 53.24 | N/A |
| 52 Week Low | $0.40 | $11.96 |
| 52 Week High | $2.09 | $18.88 |
| Indicator | LCTX | WSBF |
|---|---|---|
| Relative Strength Index (RSI) | 54.06 | 51.62 |
| Support Level | $1.56 | $17.96 |
| Resistance Level | $1.82 | $18.62 |
| Average True Range (ATR) | 0.08 | 0.34 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 74.47 | 35.91 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The majority of its revenue comes from the Community Banking segment.